Literature DB >> 20036562

2-Dialkynyl derivatives of (N)-methanocarba nucleosides: 'Clickable' A(3) adenosine receptor-selective agonists.

Dilip K Tosh1, Moshe Chinn, Lena S Yoo, Dong Wook Kang, Hans Luecke, Zhan-Guo Gao, Kenneth A Jacobson.   

Abstract

We modified a series of (N)-methanocarba nucleoside 5'-uronamides to contain dialkyne groups on an extended adenine C2 substituent, as synthetic intermediates leading to potent and selective A(3) adenosine receptor (AR) agonists. The proximal alkyne was intended to promote receptor recognition, and the distal alkyne reacted with azides to form triazole derivatives (click cycloaddition). Click chemistry was utilized to couple an octadiynyl A(3)AR agonist to azido-containing fluorescent, chemically reactive, biotinylated, and other moieties with retention of selective binding to the A(3)AR. A bifunctional thiol-reactive crosslinking reagent was introduced. The most potent and selective novel compound was a 1-adamantyl derivative (K(i) 6.5nM), although some of the click products had K(i) values in the range of 200-400nM. Other potent, selective derivatives (K(i) at A(3)AR innM) were intended as possible receptor affinity labels: 3-nitro-4-fluorophenyl (10.6), alpha-bromophenacyl (9.6), thiol-reactive isothiazolone (102), and arylisothiocyanate (37.5) derivatives. The maximal functional effects in inhibition of forskolin-stimulated cAMP were measured, indicating that this class of click adducts varied from partial to full A(3)AR agonist compared to other widely used agonists. Thus, this strategy provides a general chemical approach to linking potent and selective A(3)AR agonists to reporter groups of diverse structure and to carrier moieties. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036562      PMCID: PMC2818678          DOI: 10.1016/j.bmc.2009.12.018

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  37 in total

1.  Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.

Authors:  J M Rieger; M L Brown; G W Sullivan; J Linden; T L Macdonald
Journal:  J Med Chem       Date:  2001-02-15       Impact factor: 7.446

2.  Squaraine rotaxanes: superior substitutes for Cy-5 in molecular probes for near-infrared fluorescence cell imaging.

Authors:  James R Johnson; Na Fu; Easwaran Arunkumar; W Matthew Leevy; Seth T Gammon; David Piwnica-Worms; Bradley D Smith
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 3.  Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

Authors:  Kenneth A Jacobson; Athena M Klutz; Dilip K Tosh; Andrei A Ivanov; Delia Preti; Pier Giovanni Baraldi
Journal:  Handb Exp Pharmacol       Date:  2009

4.  2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.

Authors:  Liesbet Cosyn; Krishnan K Palaniappan; Soo-Kyung Kim; Heng T Duong; Zhan-Guo Gao; Kenneth A Jacobson; Serge Van Calenbergh
Journal:  J Med Chem       Date:  2006-12-14       Impact factor: 7.446

5.  2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors.

Authors:  K N Klotz; M J Lohse; U Schwabe; G Cristalli; S Vittori; M Grifantini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

6.  Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells.

Authors:  Tsui-Ling Hsu; Sarah R Hanson; Kuniyuki Kishikawa; Sheng-Kai Wang; Masaaki Sawa; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

7.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

8.  Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.

Authors:  Artem Melman; Ben Wang; Bhalchandra V Joshi; Zhan-Guo Gao; Sonia de Castro; Cara L Heller; Soo-Kyung Kim; Lak Shin Jeong; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2008-08-07       Impact factor: 3.641

9.  Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates.

Authors:  Judith E Berlier; Anca Rothe; Gayle Buller; Jolene Bradford; Diane R Gray; Brian J Filanoski; William G Telford; Stephen Yue; Jixiang Liu; Ching-Ying Cheung; Wesley Chang; James D Hirsch; Joseph M Beechem; Rosaria P Haugland; Richard P Haugland
Journal:  J Histochem Cytochem       Date:  2003-12       Impact factor: 2.479

10.  Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.

Authors:  Stefania Gessi; Stefania Merighi; Katia Varani; Elena Cattabriga; Annalisa Benini; Prisco Mirandola; Edward Leung; Stephen Mac Lennan; Carlo Feo; Stefania Baraldi; Pier Andrea Borea
Journal:  J Cell Physiol       Date:  2007-06       Impact factor: 6.384

View more
  13 in total

1.  Methanocarba ring as a ribose modification in ligands of G protein-coupled purine and pyrimidine receptors: synthetic approaches.

Authors:  Dilip K Tosh; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2013-12-17       Impact factor: 3.597

2.  Synthesis of BODIPY derivatives substituted with various bioconjugatable linker groups: a construction kit for fluorescent labeling of receptor ligands.

Authors:  Fabian Heisig; Sabrina Gollos; Sven J Freudenthal; Ali El-Tayeb; Jamshed Iqbal; Christa E Müller
Journal:  J Fluoresc       Date:  2013-09-20       Impact factor: 2.217

Review 3.  Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands.

Authors:  Francisco Ciruela; Víctor Fernández-Dueñas; Kenneth A Jacobson
Journal:  Neuropharmacology       Date:  2015-04-16       Impact factor: 5.250

4.  Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart.

Authors:  Bella Chanyshev; Asher Shainberg; Ahuva Isak; Alexandra Litinsky; Yelena Chepurko; Dilip K Tosh; Khai Phan; Zhan-Guo Gao; Edith Hochhauser; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2011-12-01       Impact factor: 7.658

5.  GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists.

Authors:  Angela Kecskés; Dilip K Tosh; Qiang Wei; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2011-05-12       Impact factor: 4.774

6.  Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition.

Authors:  Dilip K Tosh; Khai Phan; Francesca Deflorian; Qiang Wei; Lena S Yoo; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2012-01-11       Impact factor: 4.774

7.  Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor.

Authors:  Eszter Kozma; Elizabeth T Gizewski; Dilip K Tosh; Lucia Squarcialupi; John A Auchampach; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2013-01-31       Impact factor: 5.858

Review 8.  Fluorescent ligands for adenosine receptors.

Authors:  Eszter Kozma; P Suresh Jayasekara; Lucia Squarcialupi; Silvia Paoletta; Stefano Moro; Stephanie Federico; Giampiero Spalluto; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2012-11-05       Impact factor: 2.823

9.  Structure-Based Design, Synthesis by Click Chemistry and in Vivo Activity of Highly Selective A3 Adenosine Receptor Agonists.

Authors:  Dilip K Tosh; Silvia Paoletta; Zhoumou Chen; Steven Crane; John Lloyd; Zhan-Guo Gao; Elizabeth T Gizewski; John A Auchampach; Daniela Salvemini; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2015       Impact factor: 3.597

10.  Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles.

Authors:  P Suresh Jayasekara; Khai Phan; Dilip K Tosh; T Santhosh Kumar; Steven M Moss; Guofeng Zhang; Joseph J Barchi; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2012-11-20       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.